Sep 2026· Journal of the Formosan Medical Association = Taiwan yi zhi· 0 citations· 34 references
Medicine
TL;DR
This study developed and demonstrated the clinical applicability of disease-specific, population-specific RCI and SRB indices for Traditional Chinese-speaking patients with TLE to provide an empirical standard for evaluating meaningful cognitive changes after epilepsy surgery.
Abstract
Purpose
This study aimed to develop reliable change index (RCI) and standardized regression-based (SRB) change scores for Chinese versions of the neuropsychological tests to provide an empirical standard for evaluating meaningful cognitive changes after epilepsy surgery for patients with temporal lobe epilepsy (TLE).
Methods
Thirty-one non-operated patients with TLE were assessed twice (6-month interval) by using the Wechsler Adult Intelligence Scale-III (WAIS-III) and the subtests of the Wechsler Memory Scale-III (WMS-III) to compute RCI with the correction of practice effect and SRB equations. The predictor variables for the SRB models included the demographic variables (age, gender, education), clinical variables (age of seizure onset, seizure duration), and baseline performance. These standards were then applied to sixty patients who underwent selective amygdalohippocampectomy (SAH).
Results
Test-retest reliability was acceptable while the individual subtest variability was noted (r = 0.51 to 0.94). Baseline performance was the primary predictor in each SRB equation, accounting for 31.4% to 88.4% of the variance. Among the SAH cohort, 80.0%-100.0% remained cognitively stable across different tests. However, the patients in left SAH group exhibited a significant decline in verbal memory (20.0-23.3%), working memory and executive control (6.7-30.0%). Conversely, more than 10% of the right SAH group showed deterioration in visual memory and processing speed.
Conclusion
This study developed and demonstrated the clinical applicability of disease-specific, population-specific RCI and SRB indices for Traditional Chinese-speaking patients with TLE. These indices provide a standardized framework for accounting for practice effects, regression to the mean, and test-retest variability when interpreting meaningful cognitive changes following epilepsy surgery.
OBJECTIVE
This study aimed to investigate the measurement properties of the Multifactorial Memory Questionnaire (MMQ) for community-dwelling adults with epilepsy.
METHODS
In phase one, 24 adults with epilepsy participated in semi-structured interviews to appraise the content validity of the MMQ. In phase two, adults...
K. Thompson, Catherine Haslam, T. Ownsworth et al.· Epilepsy & Behavior· 0 citations
INTRODUCTION
Tuberous sclerosis complex (TSC) is a rare genetic disorder with a high prevalence of drug-resistant epilepsy. In such cases, epilepsy surgery may render 60% of suitable candidates seizure-free. Although seizure reduction may contribute to improvements in cognitive or language skills, little is known about...
Kevin Pearsson, Mikaela Selby, Ellen C. Broekhuizen et al.· Epilepsy & Behavior· 0 citations
Estimating premorbid cognitive capability provides a baseline to accurately identify and quantify cognitive impairments incurred following neurological illness or injury, including in epilepsy. Irregular word reading tests like the Test of Premorbid Functioning (TOPF) are routinely used for this purpose, underpinned by...
Leah M. Lombardo, S. Roberts, C. Malpas et al.· Epilepsy & Behavior· 0 citations
The findings highlight the significance of the lateralization of the epileptic focus in the development of affective psychopathological symptoms, as well as the interplay between depressive and anxiety syndromes in patients with TLE.
V. Kalinin, A. Zemlyanaya, E. A. Fedorenko et al.· Zhurnal Nevrologii i Psikhia...· 0 citations
BACKGROUND
Cognitive impairment affects between 50 and 60% of people with multiple sclerosis (PwMS). Cognitive impairment usually includes problems with memory, speed of processing information, learning, and executive functions. This can impact everyday activities and quality of life. The Multiple Sclerosis Neuropsycho...
O. Mirmosayyeb, Mohammad Mohammadi, S. Vaheb et al.· Journal of Clinical and Expe...· 0 citations
AIM
To examine the impact of cenobamate (CNB) treatment on cognitive function in patients with epilepsy.
METHODS
We assessed seventeen patients before (T0) and after treatment (T1) with CNB 200 mg/day (duration: median 5.6 months, range 3.3-11.6 months). All patients underwent a neuropsychological test battery coveri...
Hanna Ljung, P. Frid, Arne Reimers et al.· Epilepsy & Behavior· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.